Targeted Delivery of Drugs to Brain Tumors (LBNL Summer Lecture Series)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Life Sciences Division; Childrenâs Hospital Oakland Research Inst. (CHORI), Oakland, CA (United States)
Summer Lecture Series 2007: Trudy Forte of Berkeley Lab's Life Sciences Division will discuss her work developing nano-sized low-density lipoprotein (LDL) particles that can be used as a safe and effective means of delivering anticancer drugs to brain tumors, particularly glioblastoma multiforme. This is the most common malignant brain tumor in adults and one of the deadliest forms of cancer. Her research team found that the synthetic LDL particles can target and kill such tumors cells in vitro. The nanoparticles are composed of a lipid core surrounded by a peptide. The peptide contains an amino acid sequence that recognizes the LDL receptor, and the lipid core has the ability to accumulate anti-cancer drugs.
- Research Organization:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- DOE Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1009104
- Resource Relation:
- Conference: Summer Lecture Series, Lawrence Berkeley National Laboratory, Berkeley, California (United States), presented on June 27, 2007
- Country of Publication:
- United States
- Language:
- English
Similar Records
Climate Change: The Role of Particles and Gases (LBNL Summer Lecture Series)
Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells